Search Results - "Benitez-Ribas D"

Targeting ALOX5 ameliorates renal tubular injury in ischemia–reperfusion-induced acute kidney injury via inhibition of ferroptosis.

Authors: Huang, Liming Tang, Qiao Li, Guoli et al.

Source: Communications Biology. 9/30/2025, Vol. 8 Issue 1, p1-13. 13p.

Therapeutic Cancer Vaccines in Gastrointestinal Malignancies: Advances, Challenges, and Emerging Strategies.

Authors: Taing, Kyle Dabirian, Keeyon Shreenivas, Aditya

Source: Cancers. May2026, Vol. 18 Issue 9, p1420. 23p.

Intradermally Administered Retinoic Acid or Vitamin D3‐Loaded Liposomes Induce Tolerogenic Skin Dendritic Cells.

Authors: Nagy, Noémi Anna Celant, Sanne G. van Capel, Toni M. M. et al.

Source: Journal of Immunology Research. 8/4/2025, Vol. 2025, p1-24. 24p.

Human CD141⁺ dendritic cells: A unique tolerogenic subset inducing immune tolerance in systemic lupus erythematosus patients.

Authors: Qin, Xiaodong Wang, Yujiao Chen, Yi et al.

Source: Rheumatology & Autoimmunity. Jun2025, Vol. 5 Issue 2, p140-146. 7p.

Exploring the Latest Developments in Natural Killer (NK) Cell-Based Therapies for Diffuse Intrinsic Pontine Glioma (DIPG).

Authors: Kaur, Kawaljit¹ (AUTHOR) drkawalmann@g.ucla.edu

Source: Biocell. 2026, Vol. 50 Issue 3, p1-16. 16p.

Immune-Centered Cross-Talk Between Cancer Cells and the Tumor Microenvironment—Implications for Therapy.

Authors: Turlej, Eliza Domaradzka, Aleksandra Koksharov, Rostyslav et al.

Source: Cancers. Feb2026, Vol. 18 Issue 3, p344. 78p.

Understanding DMG: current treatment options and prospective solutions using nanoparticles.

Authors: Mohamed A Lyzlov A Prasad R et al.

Source: Drug delivery and translational research [Drug Deliv Transl Res] 2026 Jun 17. Date of Electronic Publication: 2026 Jun 17.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances.

Authors: Kurilin, Vasily Fisher, Marina Obleukhova, Irina et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p585. 33p.

Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies.

Authors: Marchelek, Emilia Marta Nemeth, Afrodite Mohak, Sidhesh et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p123. 27p.

Innovative gene engineering and drug delivery systems for dendritic cells in cancer immunotherapy.

Authors: Prakash, Mridula Cortez, Cedric David Jayaraman, Akshaya et al.

Source: Journal of Biomedical Science. 11/1/2025, Vol. 32 Issue 1, p1-44. 44p.

In vivo CAR-T therapy: from molecular design to precision delivery.

Authors: Li H Wen W Zhao X et al.

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2026 Apr 02; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Advances in immunotherapy for colorectal cancer: overcoming resistance in mismatch repair-proficient tumors.

Authors: Keivany MR Shojae Asrami E Besharatloo M et al.

Source: Cancer cell international [Cancer Cell Int] 2026 Feb 19; Vol. 26 (1). Date of Electronic Publication: 2026 Feb 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Electronic Cited Medium: Print ISSN: 1475-2867 (Print) Linking ISSN: 14752867 NLM ISO Abbreviation: Cancer Cell Int Subsets: PubMed not MEDLINE

Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer.

Authors: Wang, Yuqian Jiang, Cheng Zhou, Huiling et al.

Source: Experimental Hematology & Oncology. 9/29/2025, Vol. 14 Issue 1, p1-64. 64p.

Assessment of Cluster of Differentiation (CD56) Expression in Correlation with other Prognostic Markers in Multiple Myeloma patients.

Authors: Mohammed Alshamy, Mohammed Gamal Arafa, Ayman Fathy Abdelmoneem, Shimaa et al.

Source: Zagazig University Medical Journal. Aug2025, Vol. 31 Issue 8, p4152-4165. 14p.

Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and Combinations.

Authors: Gallio, Chiara Esposito, Luca Passardi, Alessandro

Source: Cancers. Aug2025, Vol. 17 Issue 15, p2582. 23p.

Sensing of an HIV-1–Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance.

Authors: Suvieri, Chiara Mondanelli, Giada Orabona, Ciriana et al.

Source: Cells (2073-4409). Jul2024, Vol. 13 Issue 13, p1088. 14p.

The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming.

Authors: Buyl, Karolien Merimi, Makram Rodrigues, Robim M. et al.

Source: Biomolecules (2218-273X). Jul2024, Vol. 14 Issue 7, p852. 22p.

Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy.

Authors: Teodoro Da Silva, Laís Tiaki Tiyo, Bruna de Jesus Mota, Silvia et al.

Source: Journal of Immunology Research. 6/7/2024, Vol. 2024, p1-11. 11p.

Dendritic Cells in Cancer Immunology and Immunotherapy.

Authors: Hato, Laura Vizcay, Angel Eguren, Iñaki et al.

Source: Cancers. Mar2024, Vol. 16 Issue 5, p981. 23p.

Cellular immunotherapy in melanoma: the next frontier in cancer treatment.

Authors: Wien AL Stamtsis-Datsi A

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 Jun 18; Vol. 45 (1). Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE